C. E. Cherubin
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Hepatitis C virus research 4
-
- Viral Infections and Outbreaks Research 2
- Co-authors
- A. M. Prince (2 shared papers)Harold C. Neu (1 shared paper)John S. Marr (1 shared paper)V. Fontana (1 shared paper)G. H. Jeffries (1 shared paper)W. Szmuness (1 shared paper)Maria D. Appleman (2 shared papers)Peter N.R. Heseltine (1 shared paper)
- Journals
- The Lancet (5 papers)Clinical Infectious Diseases (4 papers)Annals of Internal Medicine (1 paper)The Journal of Infectious Diseases (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- United States
In The Last Decade
C. E. Cherubin
19 papers receiving 451 citations
Peers
Comparison fields: 5 of 89
- Hepatology 193
- Molecular Medicine 47
- Epidemiology 294
- Infectious Diseases 114
- Clinical Biochemistry 38
Countries citing papers authored by C. E. Cherubin
This map shows the geographic impact of C. E. Cherubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. E. Cherubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. E. Cherubin more than expected).
Fields of papers citing papers by C. E. Cherubin
This network shows the impact of papers produced by C. E. Cherubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. E. Cherubin. The network helps show where C. E. Cherubin may publish in the future.
Co-authors
The 17 scholars most cited alongside C. E. Cherubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1970 | 158 | |
| 2 | 1978 | 129 | |
| 3 | 1972 | 73 | |
| 4 | 1981 | 45 | |
| 5 | 1990 | 44 | |
| 6 | 1963 | 43 | |
| 7 | 1971 | 30 | |
| 8 | 1971 | 28 | |
| 9 | 1968 | 25 | |
| 10 | 1979 | 22 | |
| 11 | 1987 | 11 | |
| 12 | 1973 | 5 | |
| 13 | 1978 | 4 | |
| 14 | Deaths of narcotic addicts in New York City in 1971: those reported to be using methadone. | 1973 | 3 |
| 15 | 1968 | 3 | |
| 16 | 1973 | 3 | |
| 17 | Salmonella infection with multiple serotypes. | 1970 | 3 |
| 18 | Current status of cefotaxime sodium: a new cephalosporin. Symposium held at Phoenix, USA, 12-13 January 1981. | 1982 | 1 |
| 19 | 1972 | 1 | |
| 20 | Septicemia with non-typhoid | 1974 | 0 |
About C. E. Cherubin
C. E. Cherubin is a scholar working on Hepatology, Infectious Diseases, Molecular Medicine, Epidemiology and Pharmacology, having authored 20 papers that have together received 631 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (5 papers), Hepatitis C virus research (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers), Salmonella and Campylobacter epidemiology (3 papers), Streptococcal Infections and Treatments (2 papers), Viral Infections and Outbreaks Research (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Hepatology (193 citations), Molecular Medicine (47 citations), Epidemiology (294 citations), Infectious Diseases (114 citations) and Clinical Biochemistry (38 citations). C. E. Cherubin has collaborated with scholars based in United States. Frequent co-authors include A. M. Prince, Harold C. Neu, John S. Marr, V. Fontana, G. H. Jeffries, W. Szmuness, Maria D. Appleman, Peter N.R. Heseltine, RobertH. Purcell and Archie D. Hess. Their work appears in journals such as The Lancet, Clinical Infectious Diseases, Annals of Internal Medicine, The Journal of Infectious Diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.